Researchers investigating Phenotypic Therapy and Immune Escape in Cancer. Eight labs join in a @dfg_public funded unit at @unidue, @UniklinikEssen, @DKTK_.
Joined November 2019
- Tweets55
- Following196
- Followers85
- Likes64
Thanks to all participants, outstanding guest speakers & passionate researchers who joined us to celebrate 6 years of successful DFG-funded research at the #CRU337 Symposium. A great platform for collaboration & insights into therapy and immune resistance. @dfg_public @LabRoesch
🔬✨Join us for this exciting lecture hosted by CRU337 @dfg_public as part of the "Sex and Gender in the Life Sciences" series @unidue . Discover the analytical potential of sex differences in melanoma.🔗Join: uni-due.zoom-x.de/j/68548836…
#SexGenderUDE #sexandgendersensitive medicine
🎉Congratulations to Stefanie Egetemaier from our #cru337 @labRoesch for successfully defending her PhD thesis on June 26, 2024! 🎓 We're very proud of her achievement and excited to see the impact of her work within our research community. Well done! 👏 #WomenInScience #unidue
🎊Congratulations to Dr. Renata Varaljai @renivaraljai from the Roesch lab @LabRoesch for receiving the Top Young Science Best Paper Award 2024 from the UDE Medical Faculty! 🔬🏆Read the awarded paper here: nature.com/articles/s43018-0…
Clinical Research Unit CRU 337 retweeted
It was a great pleasure to have @BarbMarte from @Nature at our #Meet_the_Editor seminar series in Essen @MedEssen @UniklinikEssen @unidue. Thanks for your visit Barbara.
Clinical Research Unit CRU 337 retweeted
Our latest work in @NatureCancer shows how immunotherapy responses of patients with metastatic melanoma are linked to interleukin-17 signaling. 1/ nature.com/articles/s43018-0…
Clinical Research Unit CRU 337 retweeted
New publication by #CRC1430 and @cru337
out in @CCR_AACR: HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistance
@unidue_zmb
aacrjournals.org/clincancerr…
Today we are excited to hear Jose Maria Adrover with fascinating research on neutrophils at 5:00 PM. @niseto
Clinical Research Unit CRU 337 retweeted
Die Wege von d. #Forschung in d. Markt können kürzer + schneller werden. Hier setzt das #Förderprogramm "Validierung des technologischen und gesellschaftlichen Innovationspotenzials wissenschaftlicher Forschung - VIP+" @BMBF_Bund an validierungsfoerderung.de/fo…
@unidue @UniklinikEssen
Clinical Research Unit CRU 337 retweeted
Am 4.4. findet von 12:00 - 12:45 Uhr der nächste
Mittagsstammtisch für alle #Nachwuchswissenschaftlerinnen im Casino statt.
Eine Anmeldung ist nicht erforderlich, kommt gerne einfach spontan vorbei und nutzt die Zeit zum #Austausch und #networking @unidue @UniklinikEssen
Clinical Research Unit CRU 337 retweeted
We invite applications for a bachelor/ master position at the Institute for Experimental Immunology & Imaging in Essen.
For more information follow the link: uni-due.de/experimental-immu…
Clinical Research Unit CRU 337 retweeted
Do you want to query melanoma cohorts with molecular and clinical data for your candidate genes?
Do you want to find new correlates of clinical parameters? Then our new database might be for you:
tools.hornlab.org/cru337phen…
Many thanks to all participants of KFO 337 Kick-off Symposium (2nd Funding Period). Great meeting with renowned guests, fascinating talks and inspiring discussions! @dfg_public
Today we are at the Kick-off Symposium for the 2nd funding period for our CRU „Phenotypic Therapy and Immune Escape in Cancer“ with great speakers Aviv Regev, Camilla Jandus, Nicola Aceto, Henner Farin @dfg_public @LabRoesch
Clinical Research Unit CRU 337 retweeted
New #JITC article: Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity bit.ly/3xLdQgV
Clinical Research Unit CRU 337 retweeted
Excited to share our joint efforts on persister state-directed transitioning in melanoma led by our dedicated postdoc Heike Chauvistré.
@UniklinikEssen, @unidue_zmb, @cru337, @crc1430, @HaassLab, @TheWistar, @Fraunhofer, @UMU, @uniGoettingen
nature.com/articles/s41467-0…
🧵1/19
Thank you @dfg_public. We are ready for the next endeavour in our clinical research unit.
Die #DFG fördert 9 neue #Forschungsgruppen mit einem Gesamtvolumen v. rd. 38 Mio € f. die erste Förderperiode. Darüber hinaus beschlossen Senat & Hauptausschuss die Verlängerung von 7 #FOR für eine weitere #Förderperiode. Mehr zu den Themen & Projekten.
➡️dfg.de/service/presse/presse…
Thanks for joining our International Symposium “Phenotypic Therapy and Immune
Escape in Cancer (PhenoTImE)” today with great presentations
@obenaufa @AngeliFriedmann
